Clinical trial
Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
NCT02906852 is registered in ClinicalTrials.gov with Inivata as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study to Evaluate the Performance of Inivata Liquid Biopsy Analysis Compared With Standard Tissue Biopsy Analysis for Detection of Genomic Alterations in Patients With Advanced Non-small Cell Lung Cancer.
- Lead sponsor
- Inivata
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2016
- Completion date
- December 31, 2018
- Enrollment
- 264 (actual)
- Sites
- 35
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer